Medical Management of Aquagenic Pruritus
Phototherapy with narrowband UVB (NB-UVB), broadband UVB (BB-UVB), or combined UVA and UVB is the recommended first-line treatment for aquagenic pruritus, though evidence quality is limited and relapses are common. 1
Primary Treatment Approach
Phototherapy (First-Line)
The British Association of Dermatologists guidelines specifically recommend phototherapy for aquagenic pruritus, though with a Strength of Recommendation D (lower quality evidence). The options include:
- NB-UVB phototherapy
- BB-UVB phototherapy
- Combined UVA and UVB therapy
Important caveats: Remission is typically short-lived, with symptoms recurring 3-24 weeks after treatment cessation 1. Some patients achieve longer remission (over 1 year) with combined UVA/UVB 1. Once-weekly maintenance treatment after initial response may prevent relapse 1. However, some patients show no benefit from phototherapy at all 1.
Alternative Pharmacological Options
Beta-Alanine (Emerging Evidence)
Recent research (2021-2025) demonstrates promising results with β-alanine supplementation, though this is not yet in formal guidelines:
- Dosing: Average 1.59 grams daily during exacerbations 2
- Efficacy: Average relief rating of 8.84/10 in patient surveys 2
- Side effects: Transient paresthesia in 39.6% of users 2
- Duration: Efficacy maintained at 20-week follow-up 3
This represents the most recent high-quality evidence for treatment efficacy, though it requires controlled trials for validation 3, 2, 4.
Beta-Blockers
Atenolol shows effectiveness in case reports:
- Convenient once-daily dosing
- Better side effect profile than propranolol
- May work by blocking over-activated neuronal sodium channels 5
- Long-term symptom control demonstrated 5
The guideline also mentions atenolol as an option for polycythemia vera-associated pruritus 1, suggesting broader applicability.
Opioid Antagonists
Naltrexone has demonstrated success in refractory cases:
- Modifies pruritus by influencing peripheral and central itch sensation 6
- Consider for treatment failures with other modalities
Treatment Algorithm
First-line: Initiate phototherapy (NB-UVB, BB-UVB, or combined UVA/UVB)
- If response achieved, consider weekly maintenance to prevent relapse
- Expect potential relapse 3-24 weeks after stopping
If phototherapy fails or is unavailable: Consider β-alanine supplementation (~1.6g daily)
- Warn patients about transient paresthesia
- Monitor response over several weeks
If still refractory: Trial atenolol (once daily)
- Preferred over propranolol for convenience and tolerability
Last resort: Naltrexone for severe, treatment-resistant cases
Critical Considerations
Rule out underlying conditions first: Aquagenic pruritus can be associated with polycythemia vera or other myeloproliferative neoplasms. Patients with aquagenic pruritus have higher rates of disease evolution (25.9% vs 14.4%) 7. Check complete blood count and consider hematology referral if abnormalities present.
Distinguish from aquagenic urticaria: This is a separate condition with wheals/hives requiring different management (antihistamines like cetirizine) 8.
Realistic expectations: Aquagenic pruritus shows low rates of spontaneous resolution (only 16.7% disappearance rate) 7, so long-term management strategies are typically necessary.
Avoid ineffective treatments: The evidence does not support routine antihistamines for primary aquagenic pruritus (unlike aquagenic urticaria), though they may have a role in polycythemia vera-associated cases.